Kline I - Search Results

1

The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.

Field RB, Gang M, Kline I, Venditti JM, Waravdekar VS. Field RB, et al. Among authors: kline i. J Pharmacol Exp Ther. 1972 Feb;180(2):475-83. J Pharmacol Exp Ther. 1972. PMID: 5010684 No abstract available.

2

Enhanced response of leukemia (L1210) mice to combination chemotherapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) and 5-fluorouracil (NSC-19893).

Kline I, Woodman RJ, Gang M, Waravdekar VS, Goldin A, Venditti JM. Kline I, et al. Cancer. 1971 Jun;27(6):1363-8. doi: 10.1002/1097-0142(197106)27:6<1363::aid-cncr2820270614>3.0.co;2-w. Cancer. 1971. PMID: 5088212 No abstract available.

3

Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.

Hoffman GS, Kline I, Gang M, Tyrer DD, Goldin A, Mantel N, Venditti JM. Hoffman GS, et al. Among authors: kline i. Cancer Chemother Rep. 1969 Oct;53(5):265-71. Cancer Chemother Rep. 1969. PMID: 5377613 No abstract available.

4

Evaluation of combination chemotherapy with three drugs.

Goldin A, Venditti JM, Mantel N, Kline I, Gang M. Goldin A, et al. Among authors: kline i. Cancer Res. 1968 May;28(5):950-60. Cancer Res. 1968. PMID: 5652309 No abstract available.

5

The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.

Woodman RJ, Sirica AE, Gang M, Kline I, Venditti JM. Woodman RJ, et al. Among authors: kline i. Chemotherapy. 1973;18(3):169-83. doi: 10.1159/000221259. Chemotherapy. 1973. PMID: 4119363 No abstract available.

6

Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

Kline I, Gang M, Woodman RJ, Cysyk RL, Venditti JM. Kline I, et al. Cancer Chemother Rep. 1973 Sep-Oct;57(3):299-304. Cancer Chemother Rep. 1973. PMID: 4751256 No abstract available.

7

Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).

Kline I, Woodman RJ, Gang M, Venditti JM. Kline I, et al. Cancer Chemother Rep. 1971 Feb;55(1):9-28. Cancer Chemother Rep. 1971. PMID: 5121657 No abstract available.

8

Effectiveness of antileukemic agents in mice inoculated with a leukemia L1210 variant resistant to 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196).

Tyrer DD, Kline I, Gang M, Goldin A, Venditti JM. Tyrer DD, et al. Among authors: kline i. Cancer Chemother Rep. 1969 Sep;53(4):229-41. Cancer Chemother Rep. 1969. PMID: 5384463 No abstract available.

9

Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.

Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A. Kline I, et al. Cancer Chemother Rep 2. 1971 Apr;2(1):65-133. Cancer Chemother Rep 2. 1971. PMID: 5565539 No abstract available.

10

Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice.

Kline I, Tyrer DD, Gang M, Venditti JM, Goldin A. Kline I, et al. Cancer Chemother Rep. 1968 Apr;52(3):399-404. Cancer Chemother Rep. 1968. PMID: 5670722 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters